Immuno-Oncology At US FDA: Where Are The PD-1/L1 Inhibitor Applications?
Executive Summary
Infographic guide to the almost 40 indications for burgeoning PD-1/L1 checkpoint inhibitor class either approved or under review, from the Pink Sheet's FDA Performance Tracker.